Overview

A Translational Study of Single Agent Olaparib in the Treatment of Advanced Oesophagogastric Cancer

Status:
Recruiting
Trial end date:
2022-02-14
Target enrollment:
Participant gender:
Summary
SOlar is a multi-centre phase II clinical trial of single agent olaparib in advanced oesophagogastric cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Royal Marsden NHS Foundation Trust
Collaborator:
AstraZeneca
Treatments:
Olaparib